Novavax says COVID-19 vaccine 89% effective in UK trial, less in South Africa, shares jump
By Julie SteenhuysenCHICAGO, Jan 28 (Reuters) - Novavax Inc said on Thursday its coronavirus vaccine was 89.3% effective in preventing COVID-19 in a trial...
By Julie SteenhuysenCHICAGO, Jan 28 (Reuters) - Novavax Inc said on Thursday its coronavirus vaccine was 89.3% effective in preventing COVID-19 in a trial...